New research from Indiana University School of Medicine scientists has revealed that a well-known cancer-fighting gene also ...
Ironfist Therapeutics ("Ironfist"), a preclinical-stage company developing a nanomedicine radiopharmaceutical (Tamrada) that selectively targets tumor associated macrophages without a targeting ligand ...
The super adjuvant vaccine also protected against the spread of cancer to the lungs. When exposed to melanoma cells systemically, which mimics how cancer metastasizes, none of the ...
By integrating key advances from multiple laboratories and disciplines, researchers provide a framework for understanding how ...
A new research paper was published in Volume 16 of Oncotarget on October 6, 2025, titled “ACTM-838, a novel systemically ...
Panelists discuss how the expanding treatment landscape for Crohn’s disease includes multiple mechanisms of action such as ...
The "CD47 Inhibitors Drug Market Opportunity, Clinical Application by Indications & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering.The quest for new cancer ...
A new research paper was published in Volume 16 of Oncotarget on October 6, 2025, titled "ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL ...
Scientists at Virginia Tech's Fralin Biomedical Research Institute at VTC and their collaborators are exploring emerging ...
Discover a study using CD206-targeted imaging to predict immunotherapy response and outcomes in patients with advanced melanoma.
RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and Lantern Pharma, Inc. (Nasdaq:LTRN) on ...